{"schema_version":"secwatch.filing_event.v1","accession":"0000313143-24-000047","form_type":"8-K/A","ticker":"HAE","cik":"0000313143","company_name":"HAEMONETICS CORP","filed_at":"2024-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.471067+00:00","generated_at":"2026-05-31T15:29:19.028178+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Haemonetics shareholders elect directors, approve executive pay and auditor at 2024 annual meeting","bullets":["All 9 director nominees elected with ~47.1M–47.6M votes each; no director received less than 46.8M for.","Advisory vote on executive compensation passed with 46.2M for, 1.46M against, 142k abstain.","Ratification of Ernst & Young as auditor for FY ending March 29, 2025: 47.74M for, 1.05M against.","Quorum of 48.9M shares (95.99% of outstanding) present at the July 25, 2024 meeting.","Amendment corrects clerical error in original 8-K regarding fiscal year reference in proposal 3 description."],"urls":{"canonical":"https://secwatch.observer/filing/0000313143-24-000047","json":"https://secwatch.observer/filing/0000313143-24-000047.json","markdown":"https://secwatch.observer/filing/0000313143-24-000047.md","text":"https://secwatch.observer/filing/0000313143-24-000047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313143/000031314324000047/0000313143-24-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313143/000031314324000047/hae-20240725.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:29:19.028178+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}